Jade Biosciences, Inc.
JBIO
$13.97
-$0.28-1.97%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Net Income | -31.93M | -25.18M | -32.13M | -38.17M | |
| Total Depreciation and Amortization | 9.00K | 12.00K | -3.00K | 8.00K | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 8.81M | 4.10M | 10.15M | 17.82M | |
| Change in Net Operating Assets | -10.54M | -1.07M | 1.83M | 1.58M | |
| Cash from Operations | -33.65M | -22.12M | -20.16M | -18.76M | |
| Capital Expenditure | -3.00K | -57.00K | -136.00K | -- | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -98.16M | -148.65M | -- | -- | |
| Cash from Investing | -98.16M | -148.71M | -136.00K | -- | |
| Total Debt Issued | -190.45M | -14.55M | 205.00M | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | 385.38M | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -24.77M | 14.55M | -13.69M | -700.00K | |
| Cash from Financing | 170.16M | 0.00 | 191.31M | -700.00K | |
| Foreign Exchange rate Adjustments | -17.00K | -4.00K | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 38.33M | -170.84M | 171.01M | -19.46M | |